DE69325167T2 - Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten - Google Patents

Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten

Info

Publication number: DE69325167T2
Authority: DE; Germany
Prior art keywords: condensed; receptor antagonists; indol derivatives; indol; derivatives
Prior art date: 1992-03-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69325167T

Other languages

English (en)

Other versions

DE69325167D1 (de

Inventor

Laramie Mary Gaster

Paul Adrian Wyman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-12

Filing date

1993-03-10

Publication date

2000-01-20

1992-03-12 Priority claimed from GB929205428A external-priority patent/GB9205428D0/en

1992-09-05 Priority claimed from GB929218846A external-priority patent/GB9218846D0/en

1992-12-29 Priority claimed from GB929227045A external-priority patent/GB9227045D0/en

1993-03-10 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1999-07-08 Publication of DE69325167D1 publication Critical patent/DE69325167D1/de

2000-01-20 Application granted granted Critical

2000-01-20 Publication of DE69325167T2 publication Critical patent/DE69325167T2/de

2013-03-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69325167T 1992-03-12 1993-03-10 Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten Expired - Lifetime DE69325167T2 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB929205428A GB9205428D0 (en)	1992-03-12	1992-03-12	Pharmaceuticals
GB929218846A GB9218846D0 (en)	1992-09-05	1992-09-05	Pharmaceuticals
GB929227045A GB9227045D0 (en)	1992-12-29	1992-12-29	Pharmaceuticals
PCT/GB1993/000506 WO1993018036A1 (en)	1992-03-12	1993-03-10	Condensed indole derivatives as 5ht4-receptor antagonists

Publications (2)

Publication Number	Publication Date
DE69325167D1 DE69325167D1 (de)	1999-07-08
DE69325167T2 true DE69325167T2 (de)	2000-01-20

Family

ID=27266092

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69333504T Expired - Lifetime DE69333504T2 (de)	1992-03-12	1993-03-10	N-(1-nButyl-4-piperidyl)methyl-3,4-dihydro-2H-1,3 oxazino 3,2-a indol-10-carboxamid oder ein pharmazeutisch annehmbares Salz davon
DE69325167T Expired - Lifetime DE69325167T2 (de)	1992-03-12	1993-03-10	Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE69333504T Expired - Lifetime DE69333504T2 (de)	1992-03-12	1993-03-10	N-(1-nButyl-4-piperidyl)methyl-3,4-dihydro-2H-1,3 oxazino 3,2-a indol-10-carboxamid oder ein pharmazeutisch annehmbares Salz davon

Country Status (30)

Country	Link
EP (2)	EP0884319B1 (de)
JP (1)	JP2831467B2 (de)
KR (1)	KR100282730B1 (de)
CN (2)	CN1043893C (de)
AP (1)	AP401A (de)
AT (2)	ATE180785T1 (de)
AU (1)	AU671102B2 (de)
CA (1)	CA2131797C (de)
CY (1)	CY2510B1 (de)
CZ (1)	CZ286194B6 (de)
DE (2)	DE69333504T2 (de)
DK (2)	DK0630376T3 (de)
ES (2)	ES2132223T3 (de)
FI (1)	FI107158B (de)
GR (1)	GR3030668T3 (de)
HK (1)	HK1012352A1 (de)
HU (1)	HU219121B (de)
IL (1)	IL105003A (de)
MA (1)	MA22819A1 (de)
MX (1)	MX9301348A (de)
MY (1)	MY110110A (de)
NO (1)	NO303638B1 (de)
NZ (1)	NZ249565A (de)
PT (1)	PT884319E (de)
RU (1)	RU2104279C1 (de)
SG (1)	SG50693A1 (de)
SI (1)	SI9300114B (de)
SK (1)	SK281423B6 (de)
UA (1)	UA41311C2 (de)
WO (1)	WO1993018036A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5852014A (en) *	1992-03-12	1998-12-22	Smithkline Beecham P.L.C.	Condensed indole derivatives as 5HT4 -receptor antagonists
GB9316195D0 (en) *	1993-08-05	1993-09-22	Smithkline Beecham Plc	Pharmaceuticals
US5998409A (en) *	1992-03-12	1999-12-07	Smithkline Beecham Plc	Condensed indole derivatives as 5HT4 -receptor antagonists
MX9305947A (es) *	1992-09-29	1994-06-30	Smithkline Beecham Plc	Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
JPH08502283A (ja) *	1992-10-16	1996-03-12	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	５−ｈｔ▲下４▼レセプターアンタゴニスト用の縮合環系ｎ−アルキルピペリジニル−４−メチルカルボン酸エステル／アミド
NZ257545A (en) *	1992-11-05	1997-01-29	Smithkline Beecham Plc	Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions
FR2699921B1 (fr) *	1992-12-30	1995-02-10	Synthelabo	Dérivés d'acide 2-(thien-2-yl)imidazo[2,1-b]benzothiazole-3-acétique, leur préparation et leur application en thérapeutique.
GB9303340D0 (en) *	1993-02-19	1993-04-07	Smithkline Beecham Plc	Pharmaceuticals
GB9310582D0 (en) *	1993-05-22	1993-07-07	Smithkline Beecham Plc	Pharmaceuticals
GB9312348D0 (en) *	1993-06-16	1993-07-28	Smithkline Beecham Plc	Pharmaceuticals
KR100219922B1 (ko) *	1996-05-16	1999-09-01	이서봉	신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법
AU3464397A (en) *	1996-07-02	1998-01-21	Sang Sup Jew	Oxirane carboxylic acid derivative and its manufacturing method
TR199900321T2 (xx) *	1996-08-16	1999-04-21	Smithkline Beecham P.L.C.	N-(1-nbutil - 4 - piperidil)metil) -3,4-dihidro -2H- (1,3) oksazino (3.2A) indol-10- Karboksamit haz�rlama prosesi ve prosesteki tuzlar ve ara �r�nler.
US6100397A (en) *	1996-08-16	2000-08-08	Smithkline Beecham Plc	Process for the preparation of N-[(1-n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a] indole-10-carboxamide and salts and intermediates in the process
GB9618967D0 (en) *	1996-09-11	1996-10-23	Smithkline Beecham Plc	Pharmaceuticals
GB9725933D0 (en) *	1997-12-05	1998-02-04	Smithkline Beecham Plc	Pharmaceuticals
US6251893B1 (en) *	1998-06-15	2001-06-26	Nps Allelix Corp.	Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
US20020091271A1 (en)	1998-07-16	2002-07-11	Smithkline Beecham Plc	Process for the preparation of an indole derivative
GB9819035D0 (en) *	1998-09-01	1998-10-28	Cerebrus Res Ltd	Chemical compounds VII
DE69935600T2 (de) *	1998-09-10	2007-12-06	F. Hoffmann-La Roche Ag	Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten
GB9820294D0 (en) *	1998-09-17	1998-11-11	Smithkline Beecham Plc	Pharmaceuticals
US6545004B1 (en)	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
AU782870C (en) *	2000-08-07	2007-03-15	Glaxo Group Limited	The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
AU2005203196B9 (en) *	2000-08-07	2009-04-09	Glaxo Group Limited	The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
KR20030027010A (ko) *	2000-08-07	2003-04-03	라보라뜨와르 글락소스미스클라인	심방 세동 예방 또는 치료용 의약의 제조에서의 5ｈｔ4수용체 길항제의 용도
AU782863C (en) *	2000-08-07	2006-08-31	Glaxo Group Limited	The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
AU7655801A (en) *	2000-08-08	2002-02-18	Smithkline Beecham Plc	Pharmaceutical composition comprising condensed indole compound
NZ535261A (en) *	2000-08-08	2004-12-24	Smithkline Beecham P	A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide
ATE329581T1 (de) *	2002-02-14	2006-07-15	Glaxo Group Ltd	Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
GB0211230D0 (en)	2002-05-16	2002-06-26	Medinnova Sf	Treatment of heart failure
ITMI20031468A1 (it)	2003-07-18	2005-01-19	Acraf	Farmaco ativo nel dolore neuropatico
ITMI20031467A1 (it) *	2003-07-18	2005-01-19	Acraf	Farmaco attivo nel dolore neuropatico
CA2551171C (en)	2003-12-23	2012-07-10	Bio-Medisinsk Innovasjon As	Modulators of peripheral 5-ht receptors
JP4612301B2 (ja) *	2003-12-26	2011-01-12	広栄化学工業株式会社	１−アルキル−４−アミノメチルピペリジンの製造法
MX2009013815A (es)	2007-06-22	2010-03-01	Arqule Inc	Compuestos de quinazolinona y metodos de uso para los mismos.
GB0905641D0 (en) *	2009-04-01	2009-05-13	Serodus As	Compounds
WO2021116487A1 (en)	2019-12-13	2021-06-17	Som Innovation Biotech, S.A.	Compounds for use in the treatment of niemann-pick c disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2557342A1 (de) *	1975-12-19	1977-06-30	Hoechst Ag	Basisch substituierte indolderivate und verfahren zu ihrer herstellung
AU622330B2 (en) *	1989-06-23	1992-04-02	Takeda Chemical Industries Ltd.	Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
CA2030051C (en) *	1989-11-17	2001-08-07	Haruhiko Kikuchi	Indole derivatives
US5189041A (en) *	1990-11-16	1993-02-23	Syntex (U.S.A.) Inc.	Tricyclic 5-ht3 receptor antagonists
GB9103862D0 (en) *	1991-02-25	1991-04-10	Glaxo Group Ltd	Chemical compounds
US5206382A (en) *	1991-06-27	1993-04-27	Fidia Georgetown Institute For The Neurosciences	Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

1993
- 1993-03-10 AP APAP/P/1993/000494A patent/AP401A/en active
- 1993-03-10 DK DK93905561T patent/DK0630376T3/da active
- 1993-03-10 SI SI9300114A patent/SI9300114B/sl active Search and Examination
- 1993-03-10 JP JP5515490A patent/JP2831467B2/ja not_active Expired - Lifetime
- 1993-03-10 UA UA94095780A patent/UA41311C2/uk unknown
- 1993-03-10 SG SG1996008846A patent/SG50693A1/en unknown
- 1993-03-10 CZ CZ19942210A patent/CZ286194B6/cs not_active IP Right Cessation
- 1993-03-10 MY MYPI93000436A patent/MY110110A/en unknown
- 1993-03-10 EP EP98114130A patent/EP0884319B1/de not_active Expired - Lifetime
- 1993-03-10 PT PT98114130T patent/PT884319E/pt unknown
- 1993-03-10 CA CA2131797A patent/CA2131797C/en not_active Expired - Fee Related
- 1993-03-10 ES ES93905561T patent/ES2132223T3/es not_active Expired - Lifetime
- 1993-03-10 AT AT93905561T patent/ATE180785T1/de active
- 1993-03-10 EP EP93905561A patent/EP0630376B1/de not_active Expired - Lifetime
- 1993-03-10 ES ES98114130T patent/ES2219813T3/es not_active Expired - Lifetime
- 1993-03-10 NZ NZ249565A patent/NZ249565A/en not_active IP Right Cessation
- 1993-03-10 AT AT98114130T patent/ATE266033T1/de active
- 1993-03-10 DE DE69333504T patent/DE69333504T2/de not_active Expired - Lifetime
- 1993-03-10 WO PCT/GB1993/000506 patent/WO1993018036A1/en active IP Right Grant
- 1993-03-10 RU RU94040864A patent/RU2104279C1/ru not_active IP Right Cessation
- 1993-03-10 SK SK1078-94A patent/SK281423B6/sk not_active IP Right Cessation
- 1993-03-10 DK DK98114130T patent/DK0884319T3/da active
- 1993-03-10 HU HU9402601A patent/HU219121B/hu unknown
- 1993-03-10 DE DE69325167T patent/DE69325167T2/de not_active Expired - Lifetime
- 1993-03-10 KR KR1019940703167A patent/KR100282730B1/ko not_active IP Right Cessation
- 1993-03-10 IL IL10500393A patent/IL105003A/en not_active IP Right Cessation
- 1993-03-10 AU AU36448/93A patent/AU671102B2/en not_active Expired
- 1993-03-10 MA MA23113A patent/MA22819A1/fr unknown
- 1993-03-11 MX MX9301348A patent/MX9301348A/es not_active IP Right Cessation
- 1993-03-11 CN CN93102648A patent/CN1043893C/zh not_active Expired - Fee Related
- 1993-05-22 CN CN93107234A patent/CN1085083A/zh active Pending
1994
- 1994-09-09 NO NO943348A patent/NO303638B1/no not_active IP Right Cessation
- 1994-09-12 FI FI944204A patent/FI107158B/fi not_active IP Right Cessation
1998
- 1998-12-15 HK HK98113467A patent/HK1012352A1/xx not_active IP Right Cessation
1999
- 1999-06-30 GR GR990401755T patent/GR3030668T3/el unknown
2005
- 2005-04-12 CY CY0500021A patent/CY2510B1/xx unknown

Also Published As

Publication number	Publication date
DK0630376T3 (da)	1999-06-23
MA22819A1 (fr)	1993-10-01
EP0884319A3 (de)	1999-02-10
IL105003A0 (en)	1993-07-08
AU671102B2 (en)	1996-08-15
NZ249565A (en)	1997-07-27
SK281423B6 (sk)	2001-03-12
DK0884319T3 (da)	2004-08-30
PT884319E (pt)	2004-09-30
KR100282730B1 (ko)	2001-02-15
NO943348D0 (no)	1994-09-09
CN1078471A (zh)	1993-11-17
RU94040864A (ru)	1996-07-20
CZ286194B6 (cs)	2000-02-16
DE69333504D1 (de)	2004-06-09
ES2132223T3 (es)	1999-08-16
HU9402601D0 (en)	1994-12-28
FI944204A0 (fi)	1994-09-12
FI944204A (fi)	1994-09-12
HUT71121A (en)	1995-11-28
CY2510B1 (en)	2005-12-23
FI107158B (fi)	2001-06-15
CA2131797A1 (en)	1993-09-16
CN1043893C (zh)	1999-06-30
NO943348L (no)	1994-11-09
DE69333504T2 (de)	2005-05-12
ES2219813T3 (es)	2004-12-01
SI9300114A (sl)	1993-12-31
CA2131797C (en)	2010-05-18
AU3644893A (en)	1993-10-05
IL105003A (en)	1996-09-12
MX9301348A (es)	1993-09-01
SI9300114B (sl)	2006-08-31
JPH07504433A (ja)	1995-05-18
EP0884319B1 (de)	2004-05-06
GR3030668T3 (en)	1999-10-29
SG50693A1 (en)	1998-07-20
WO1993018036A1 (en)	1993-09-16
ATE180785T1 (de)	1999-06-15
DE69325167D1 (de)	1999-07-08
CN1085083A (zh)	1994-04-13
AP9300494A0 (en)	1993-04-30
NO303638B1 (no)	1998-08-10
HU219121B (hu)	2001-02-28
SK107894A3 (en)	1995-04-12
UA41311C2 (uk)	2001-09-17
HK1012352A1 (en)	1999-07-30
EP0630376A1 (de)	1994-12-28
RU2104279C1 (ru)	1998-02-10
AP401A (en)	1995-08-29
MY110110A (en)	1998-01-27
KR950700304A (ko)	1995-01-16
CZ221094A3 (en)	1995-09-13
EP0630376B1 (de)	1999-06-02
JP2831467B2 (ja)	1998-12-02
EP0884319A2 (de)	1998-12-16
ATE266033T1 (de)	2004-05-15

Legal Events

Date	Code	Title	Description
2000-06-29	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE69325167T2 (de)	2000-01-20	Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
ATE197300T1 (de)	2000-11-15	Indolderivate als 5-ht rezeptorantagoniste
ATE263151T1 (de)	2004-04-15	Indolderivate verwendbar als endothelinrezeptorantagonisten
DE69127791D1 (de)	1997-11-06	Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DE69605430D1 (de)	2000-01-05	Chinolin-2-on derivate als serotonin antagonisten
ATE226578T1 (de)	2002-11-15	Benzofuranderivate als tachykininantagonisten
DE69623306D1 (de)	2002-10-02	Pyrimidinderivate als 5ht2c-rezeptorantagonisten
DE59712958D1 (de)	2008-09-25	Substituierte Purinderivate als Vitronectinrezeptor-Antagonisten
DE69418045T2 (de)	1999-10-07	Amidderivate als 5ht1d rezeptor antagonisten
DE69417427D1 (de)	1999-04-29	Indol- und indolin-derivate als 5ht1d rezeptor antagonisten
DE69703242D1 (de)	2000-11-09	Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
FI951798A (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DE69406425D1 (de)	1997-11-27	Trizyklische heterozyklische verbindungen als 5-ht4 rezeptorantagonisten
DE69717449D1 (de)	2003-01-09	Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
ATE208764T1 (de)	2001-11-15	Isazole derivate als fibrinogen-rezeptor- antagonisten
FI963463A0 (fi)	1996-09-04	Indolijohdannaiset CCK-reseptoriantagonisteina
FI941117A (fi)	1994-09-11	Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina